Financial Modeling and Analysis

Consult, Guide, Connect.

We provide comprehensive analytical support which allows our clients to understand and maintain a competitive position in the Medicaid market place.

The Challenge

Medicaid is a dynamic marketplace with each state having its own individual policies and financial goals. This complexity requires a high level of understanding of the marketplace and the ability to create customized analytical models and services to meet our clients’ needs.

All financial modeling and analyses are calculated using the most recent utilization data reported to the Centers for Medicare and Medicaid Services.

Where We Come In

Our Medicaid Preferred Drug List (PDL) Supplemental Rebate Bid Positioning Analyses provides clients with an in-depth analytical view of the category to provide them with the necessary information to make an informed decision on whether or not to participate in the bid and what level of rebate is necessary to provide a competitive offer.

We’re able to accurately forecast rebate liabilities, and we apply these principles to understand the potential impact of government contract decisions. By forecasting whether or not paying a greater rebate for “preferred” status on a formulary will have a little or large impact on sales volume and market share, we place our clients in a profitable position by minimizing their rebates and improving their net selling price.

Medicaid Price Increase and Unit Rebate Impact Forecasting

In the competitive prescription drug marketplace, manufacturers routinely take price increases on their products, which results in increased returns in the commercial sector. However, price increases can create negative pressure on Medicaid rebates through the “CPI-Penalty” formulas required in the Medicaid rebate calculation. We’ve found it necessary to assist clients in evaluating these price increases and analyzing potential impacts on net revenue and Medicaid access for their products.

Medicaid Utilization and Cost Data Reporting

We can also provide custom reports upon request. These reports are developed from our database, which contains more than five years of Medicaid drug utilization data.